Status:
COMPLETED
Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing Pleuroscopy
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Neoplasm
Malignant Respiratory Tract Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial studies how well rapid on site evaluation of pleural touch preparations works in diagnosing cancerous fluid in between the linings of the lungs (malignant pleural effusion) in patients unde...
Detailed Description
PRIMARY OBJECTIVES: I. To estimate the specificity of rapid on site evaluation (ROSE) of touch preparations (preps) for predicting malignancy on final pathology in pleuroscopy. SECONDARY OBJECTIVES:...
Eligibility Criteria
Inclusion
- Patients who will undergo pleuroscopy with biopsy
Exclusion
- Patients with known malignant pleural effusion
- Inability or unwillingness to give informed consent
Key Trial Info
Start Date :
January 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2025
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03868579
Start Date
January 10 2018
End Date
February 27 2025
Last Update
March 5 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
2
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States, 37232
3
M D Anderson Cancer Center
Houston, Texas, United States, 77030
4
Nicosia General Hospital
Nicosia, Cyprus